搜索

SSY Group Limited

SSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products and medical packaging materials. It ranks among the top 100 enterprises in China's pharmaceutical industry and the excellent export-oriented enterprises in chemical and pharmaceutical industry preparation. In 2007, the company waslisted on the main board of Hong Kong (SSY Group Limited, 02005.HK).

  • icon

    10

    The Group has 10 subsidiaries

  • icon

    4800

    The Group has 4800 employees

  • icon

    74

    Assets of 7.4 billion RMB

  • icon

    30

    Annual production capacity of injection has attained 3 billion(ampoule/bottle/bag)

  • icon

    60

    Main business income has reached 6 billion RMB

News Center

There is currently no information to display
Please add data record on website background.

Energizing industry optimization, intelligent upgrading and green development

09/03/2022

With the continuous improvement of the world pharmaceutical development level, the development of the related medical packaging industry is also in the ascendant. According to preliminary estimates
See more information

Pursue "green" and integrate development

08/17/2022

For several days, the reporter interviewed in Shijiazhuang No.4 Pharmaceutical Group. Walking in every factory, it seemed that he had a feeling of "wandering in the garden". "Garden style" enterprises leave a deep "first impression" on every visitor.
See more information

Innovation leads the cohesion "butterfly change"

08/15/2022

As night fell, the bright and broad laboratory of Shijiazhuang No.4 Pharmaceutical Research and Development Center was brightly lit.
See more information
Polypropylene infusion bottle packaging metronidazole sodium chloride injection approved
2022-09-07

Polypropylene infusion bottle packaging metronidazole sodium chloride injection approved

After obtaining the approval documents for the production of Agatroban API and the first approved azithromycin dry suspension in China, Shijiazhuang No.4 Pharmaceutical Group achieved another success in product development.
See more
SJZ No.4 Pharmaceutical Agatroban API approved
2022-09-07

SJZ No.4 Pharmaceutical Agatroban API approved

Recently, Agatroban, which was declared by Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang No.4 Pharmaceutical Group, was approved by the State Drug Administration to be registered as an API for listed preparations.
See more
Azithromycin dry suspension was approved for the first time in China
2022-09-05

Azithromycin dry suspension was approved for the first time in China

Recently, the azithromycin dry suspension developed by Shijiazhuang No.4 Pharmaceutical Co., Ltd. obtained the drug registration certificate issued by the State Drug Administration
See more
  • Technological Innovation Demonstration Enterprises recognized by the Ministry of Industry and Information Technology and the Ministry of Finance

  • Enterprise Technology Center recognized by Five Ministries and Commissions including the National Development and Reform Commission.

  • Post-Doctoral Research Center

  • Research unit of major national science and technology projects

  • National and local joint engineering laboratory

  • Large-volume injection engineering technology research center

  • Injection drug delivery system engineering technology research center

药物研究院片段2
00:01:37
药物研究院片段2
Time of issue:
2022/02/17

Lead The Future By Innovation

SSY Group Limited aims to become one of the “first echelon of pharmaceutical innovation” companies. 

And it promotes the cause of human health with strength from China!

To promote the cause of human health with strength from China

SJZ No.4 Pharmaceutical

SERVICE HOTLINE

 

400-616-8689

Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.:
+86-311-67167130
Email: office@sjzsiyao.com

Copyright © 2021 SJZ No.4 Pharmaceutical      冀ICP备05007979号-1